MRVI

NASDAQ 已收盘

Maravai LifeSciences Holdings, Inc.

6.43 USD
-0.15+0.16%
盘后 6.42 0.00%
2026-08-03
市值
$1.66B
市盈率
EPS
-0.72
股息率
52 周区间
1.99 – 7.44
成交量
1.61M
Beta
0.65
目标价
5.90
52W 低 1.9952W 高 7.44
价格走势

公司简介

Maravai LifeSciences Holdings, Inc., a life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America. It operates through two segments: TRILINK and CYGNUS. The TRILINK segment manufactures and sells products for use in the fields of gene therapy, vaccines, nucleoside chemistry, and oligonucleotide therapy, as well as molecular diagnostics, including reagents ...